Lin BioScience, Inc. 6696.TWO Stock
Lin BioScience, Inc. Price Chart
Lin BioScience, Inc. 6696.TWO Financial and Trading Overview
| Lin BioScience, Inc. stock price | 80 TWD |
| Previous Close | 148 TWD |
| Open | 149 TWD |
| Bid | 146 TWD x 0 |
| Ask | 147.5 TWD x 0 |
| Day's Range | 146 - 149.5 TWD |
| 52 Week Range | 139.5 - 245.5 TWD |
| Volume | 142.2K TWD |
| Avg. Volume | 278.97K TWD |
| Market Cap | 10.76B TWD |
| Beta (5Y Monthly) | 0.02479 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -7.08 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6696.TWO Valuation Measures
| Enterprise Value | 9.61B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 8.701511 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -21.703 |
Trading Information
Lin BioScience, Inc. Stock Price History
| Beta (5Y Monthly) | 0.02479 |
| 52-Week Change | -29.76% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 245.5 TWD |
| 52 Week Low | 139.5 TWD |
| 50-Day Moving Average | 167.41 TWD |
| 200-Day Moving Average | 180.16 TWD |
6696.TWO Share Statistics
| Avg. Volume (3 month) | 278.97K TWD |
| Avg. Daily Volume (10-Days) | 117.4K TWD |
| Shares Outstanding | 72.44M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.10% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -20.048% |
| Return on Equity (ttm) | -41.97% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -442620992 TWD |
| Net Income Avi to Common (ttm) | -313524000 TWD |
| Diluted EPS (ttm) | -4.28 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.65B TWD |
| Total Cash Per Share (mrq) | 22.75 TWD |
| Total Debt (mrq) | 46.5M TWD |
| Total Debt/Equity (mrq) | 2.68 TWD |
| Current Ratio (mrq) | 20.937 |
| Book Value Per Share (mrq) | 17.066 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -361014016 TWD |
| Levered Free Cash Flow (ttm) | -658477504 TWD |
Profile of Lin BioScience, Inc.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 68, Zhongxiao East Road |
| ZIP | 110 |
| Phone | 886 2 8780 5008 |
| Website | https://www.linbioscience.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Lin BioScience, Inc., a drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases. Its product pipeline includes LBS-008, an oral therapy for dry age-related macular degeneration (Dry AMD)and stargardt diseases (STGD1), which is under Phase 3 clinical trial to evaluate safety and efficacy in adolescent STGD1 and under phase 2 or phase 3 clinical trial to evaluate safety and efficacy in Dry AMD; LBS-007, a natural non-ATP CDC7 inhibitor for the treatment of cancers; LBS-002, an anti-tubulin to treat primary and metastatic brain tumors; and LBS-009, an oral therapy for the treatment of non-alcoholic fatty liver disease and type 2 diabetes. The company is headquartered in Taipei, Taiwan.
Q&A For Lin BioScience, Inc. Stock
What is a current 6696.TWO stock price?
Lin BioScience, Inc. 6696.TWO stock price today per share is 80 TWD.
How to purchase Lin BioScience, Inc. stock?
You can buy 6696.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lin BioScience, Inc.?
The stock symbol or ticker of Lin BioScience, Inc. is 6696.TWO.
Which industry does the Lin BioScience, Inc. company belong to?
The Lin BioScience, Inc. industry is Biotechnology.
How many shares does Lin BioScience, Inc. have in circulation?
The max supply of Lin BioScience, Inc. shares is 78.56M.
What is Lin BioScience, Inc. Price to Earnings Ratio (PE Ratio)?
Lin BioScience, Inc. PE Ratio is now.
What was Lin BioScience, Inc. earnings per share over the trailing 12 months (TTM)?
Lin BioScience, Inc. EPS is -7.08 TWD over the trailing 12 months.
Which sector does the Lin BioScience, Inc. company belong to?
The Lin BioScience, Inc. sector is Healthcare.